- Home
- NVAX vs SPT Comparison
NVAX vs SPT Comparison
Compare NVAX & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- SPT
- Stock Information
- Founded
- NVAX 1987
- SPT 2010
- Country
- NVAX United States
- SPT United States
- Employees
- NVAX N/A
- SPT N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SPT Computer Software: Prepackaged Software
- Sector
- NVAX Health Care
- SPT Technology
- Exchange
- NVAX Nasdaq
- SPT Nasdaq
- Market Cap
- NVAX 2.0B
- SPT 1.6B
- IPO Year
- NVAX 1995
- SPT 2019
- Fundamental
- Price
- NVAX $8.47
- SPT $32.10
- Analyst Decision
- NVAX Buy
- SPT Buy
- Analyst Count
- NVAX 6
- SPT 14
- Target Price
- NVAX $17.83
- SPT $48.00
- AVG Volume (30 Days)
- NVAX 5.8M
- SPT 595.2K
- Earning Date
- NVAX 11-12-2024
- SPT 11-07-2024
- Dividend Yield
- NVAX N/A
- SPT N/A
- EPS Growth
- NVAX N/A
- SPT N/A
- EPS
- NVAX N/A
- SPT N/A
- Revenue
- NVAX $885,193,000.00
- SPT $392,402,000.00
- Revenue This Year
- NVAX N/A
- SPT $22.76
- Revenue Next Year
- NVAX N/A
- SPT $16.96
- P/E Ratio
- NVAX N/A
- SPT N/A
- Revenue Growth
- NVAX N/A
- SPT 26.70
- 52 Week Low
- NVAX $3.53
- SPT $25.05
- 52 Week High
- NVAX $23.86
- SPT $68.41
- Technical
- Relative Strength Index (RSI)
- NVAX 41.69
- SPT 66.33
- Support Level
- NVAX $6.81
- SPT $27.79
- Resistance Level
- NVAX $10.39
- SPT $29.94
- Average True Range (ATR)
- NVAX 0.66
- SPT 1.48
- MACD
- NVAX 0.09
- SPT 0.36
- Stochastic Oscillator
- NVAX 46.37
- SPT 96.63
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
About SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. The firm generates majority revenue from software subscriptions.